Skip To Main Content
View Full Results
  • Resource
  • BR1DGE
  • Monitoring
  • Staging
  • Infographic

Islet Autoantibodies in T1D

The number, type, and titer of islet autoantibodies detected in T1D screening tests provide valuable information about potential progression to clinical T1D. 

Learning Objectives

  • Recognize that islet autoantibodies are biomarkers for T1D disease activity
  • Understand that islet autoantibody number, type and titer can help predict progression to clinical T1D

Summary

This infographic provides a concise overview of the role of islet autoantibodies as biomarkers of disease activity in T1D. It outlines how the number, type, and titer of islet autoantibodies detected in T1D screening tests can help predict progression to clinical T1D.

Download

Islet autoantibodies Screening
MAT-GLB-2405116-1.0 - 01/2025
Similar Content
Autoimmune T1D Imposes a Psychosocial Burden on Affected Children and Their Carers
  • Disease Burden
  • Monitoring
  • Staging
  • Video

Autoimmune T1D Imposes a Psychosocial Burden on Affected Children and Their Carers

Early identification of presymptomatic autoimmune T1D may reduce the psychological burden experienced at diagnosis by giving time for preparation and education

Discover more
Implications for Children Diagnosed at Clinical Onset of T1D Without Early Identification
  • Disease Burden
  • Staging
  • Video

Potential Implications for Children Diagnosed at Clinical Onset of T1D Stage 3

Rosa is an 8-year-old child with presymptomatic autoimmune T1D, but neither she nor her family know this yet. Without prior knowledge, she may be at increased risk of DKA at clinical onset of T1D

Discover more
Exploring Guidance for Monitoring
  • Monitoring
  • Video

Guidance for Monitoring

People positive for at least one islet autoantibody should be monitored regularly

Discover more